DonaldRFlemingMD

Breast Cancer, Hematologic Oncology, Thoracic Cancer

director of Davis Medical Center cancer care

Dr. Fleming is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
801 Harrison Ave
Elkins, WV 26241
Phone+1 304-637-3640

Fax+1 304-637-3644

University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1993
University of Louisville School of MedicineResidency, Internal Medicine, 1986 - 1989
University of Louisville School of MedicineClass of 1986

PubMed

53 citations
Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study.
Donald R. Fleming, Mary Kay Rayens, Juanita Garrison
The American Journal of Medicine. 1997-03-01
210 citations
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.
Lajos Pusztai, Peter Wagner, Nuhad K. Ibrahim, Edgardo Rivera, Richard L. Theriault
Cancer. 2005-08-15
21 citations
Challenges in oncology. Case 2. Radiation recall associated with docetaxel.
Muffaddal Morkas, Donald R. Fleming, Michael Hahl
Journal of Clinical Oncology. 2002-02-01

Journal Articles

Spontaneous Splenic Rupture in Polycythemia Vera
Moore C, Fleming D, Rogers M, Clin Oncol and Research, 5/3/2018
,. Toward Personalized Medicine of Lung Cancer: Response to Nontargeted Therapy in Invasive Pulmonary Adenocarcinoma as a Function of Tumor Cell Differentiation
P H Hartel, J Hartel, J C Fanburg-Smith, W Gilmore, D R Fleming, S M Barnett, R Mudry, J E Parker, INT J SURG PATHOL, 5/1/2013